JP2015503583A5 - - Google Patents

Download PDF

Info

Publication number
JP2015503583A5
JP2015503583A5 JP2014551234A JP2014551234A JP2015503583A5 JP 2015503583 A5 JP2015503583 A5 JP 2015503583A5 JP 2014551234 A JP2014551234 A JP 2014551234A JP 2014551234 A JP2014551234 A JP 2014551234A JP 2015503583 A5 JP2015503583 A5 JP 2015503583A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
use according
formulated
component
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014551234A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015503583A (ja
Filing date
Publication date
Priority claimed from US13/343,332 external-priority patent/US20120135050A1/en
Priority claimed from US13/424,000 external-priority patent/US8236857B2/en
Priority claimed from US13/487,348 external-priority patent/US20120244221A1/en
Application filed filed Critical
Priority claimed from PCT/US2012/051888 external-priority patent/WO2013103390A1/en
Publication of JP2015503583A publication Critical patent/JP2015503583A/ja
Publication of JP2015503583A5 publication Critical patent/JP2015503583A5/ja
Pending legal-status Critical Current

Links

JP2014551234A 2012-01-04 2012-08-22 排尿頻度を減少させるための延長放出製剤およびその使用の方法 Pending JP2015503583A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US13/343,332 US20120135050A1 (en) 2010-07-08 2012-01-04 Extended-release formulation for reducing the frequency of urination and method of use thereof
US13/343,332 2012-01-04
US13/424,000 US8236857B2 (en) 2010-07-08 2012-03-19 Extended-release formulation for reducing the frequency of urination and method of use thereof
US13/424,000 2012-03-19
US13/487,348 2012-06-04
US13/487,348 US20120244221A1 (en) 2010-07-08 2012-06-04 Extended-release formulation for reducing the frequency of urination and method of use thereof
PCT/US2012/051888 WO2013103390A1 (en) 2012-01-04 2012-08-22 Extended-release formulation for reducing the frequency of urination and method of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016178118A Division JP2017031172A (ja) 2012-01-04 2016-09-13 排尿頻度を減少させるための延長放出製剤およびその使用の方法

Publications (2)

Publication Number Publication Date
JP2015503583A JP2015503583A (ja) 2015-02-02
JP2015503583A5 true JP2015503583A5 (cg-RX-API-DMAC7.html) 2015-08-27

Family

ID=48745355

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2014551234A Pending JP2015503583A (ja) 2012-01-04 2012-08-22 排尿頻度を減少させるための延長放出製剤およびその使用の方法
JP2016178118A Pending JP2017031172A (ja) 2012-01-04 2016-09-13 排尿頻度を減少させるための延長放出製剤およびその使用の方法
JP2018016869A Pending JP2018087217A (ja) 2012-01-04 2018-02-02 排尿頻度を減少させるための延長放出製剤およびその使用の方法
JP2019203550A Pending JP2020037575A (ja) 2012-01-04 2019-11-08 排尿頻度を減少させるための延長放出製剤およびその使用の方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2016178118A Pending JP2017031172A (ja) 2012-01-04 2016-09-13 排尿頻度を減少させるための延長放出製剤およびその使用の方法
JP2018016869A Pending JP2018087217A (ja) 2012-01-04 2018-02-02 排尿頻度を減少させるための延長放出製剤およびその使用の方法
JP2019203550A Pending JP2020037575A (ja) 2012-01-04 2019-11-08 排尿頻度を減少させるための延長放出製剤およびその使用の方法

Country Status (13)

Country Link
US (3) US8685453B2 (cg-RX-API-DMAC7.html)
JP (4) JP2015503583A (cg-RX-API-DMAC7.html)
KR (2) KR20180025993A (cg-RX-API-DMAC7.html)
AU (2) AU2012363789B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014016661A8 (cg-RX-API-DMAC7.html)
CA (1) CA2856677A1 (cg-RX-API-DMAC7.html)
IL (1) IL232715A0 (cg-RX-API-DMAC7.html)
MX (1) MX2014008283A (cg-RX-API-DMAC7.html)
MY (1) MY173582A (cg-RX-API-DMAC7.html)
RU (1) RU2603471C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201500407XA (cg-RX-API-DMAC7.html)
WO (1) WO2013103390A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201404606B (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9532959B2 (en) 2010-07-08 2017-01-03 Wellesley Pharmaceuticals, Llc Pharmaceutical formulation for reducing frequency of urination and method of use thereof
US8748110B2 (en) 2011-07-18 2014-06-10 Critical Care Diagnostics, Inc. Methods of treating cardiovascular diseases and predicting the efficacy of exercise therapy
US10711230B2 (en) * 2012-03-30 2020-07-14 Givaudan Sa N-acyl proline derivatives as food flavoring compounds
CN106714805A (zh) * 2014-06-06 2017-05-24 韦尔斯利医药有限公司 降低排尿频率的药物制剂及其使用方法
CN107072971A (zh) * 2014-09-24 2017-08-18 韦尔斯利医药有限公司 用于减轻膀胱痉挛的药学制剂及其使用方法
AU2016317092A1 (en) * 2015-09-01 2018-04-26 Wellesley Pharmaceuticals, Llc Extended, delayed and immediate release formulation method of manufacturing and use thereof
AU2016317093A1 (en) * 2015-09-01 2018-04-26 Wellesley Pharmaceuticals, Llc Delayed-release formulations, methods of making and use thereof
AU2016331879A1 (en) * 2015-09-30 2018-05-17 Wellesley Pharmaceuticals, Llc Composition for reducing the frequency of urination, method of making and use thereof
TW201726114A (zh) * 2015-11-23 2017-08-01 魏斯理製藥公司 降低排尿頻率之組成物、其製備方法、及其應用
JP7229012B2 (ja) * 2018-12-25 2023-02-27 小林製薬株式会社 内服用医薬組成物
JP2019069991A (ja) * 2018-12-27 2019-05-09 ウェルズリー ファーマスーティカルズ、エルエルシー 膀胱痙攣を低減するための医薬製剤およびその使用の方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122004000032I2 (de) * 1991-09-06 2006-02-09 Mcneilab Inc Zusammensetzung die eine Tramadol-Verbindung und Acetaminophen enth{lt, und ihre Verwendung
WO1998046216A1 (fr) * 1997-04-11 1998-10-22 Nippon Shinyaku Co., Ltd. Traitements des mictions frequentes et de l'incontinence urinaire
US7138393B2 (en) * 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
JP3660979B2 (ja) * 2000-09-05 2005-06-15 国立大学法人金沢大学 夜間頻尿症の治療剤、夜間頻尿症の予防剤
RU2193401C1 (ru) * 2001-04-02 2002-11-27 Аль-Шукри Салман Хасунович Способ лечения гиперактивности мочевого пузыря
JPWO2003043655A1 (ja) * 2001-11-19 2005-03-10 小野薬品工業株式会社 頻尿の治療剤
WO2003070233A1 (en) * 2002-02-19 2003-08-28 Pharmacia Corporation Use of cyclooxygenase inhibitors and antimuscarinic agents for the treatment of incontinence
AU2003281044A1 (en) * 2002-07-11 2004-02-02 Takeda Pharmaceutical Company Limited Pyrrolopyridine derivative and use thereof
KR100522239B1 (ko) * 2002-07-16 2005-10-18 주식회사 서울제약 아세트아미노펜을 함유하는 제어방출성의 경구용 제제
US20050152905A1 (en) * 2002-08-22 2005-07-14 Omoigui Osemwota S. Method of biochemical treatment of persistent pain
US20040054008A1 (en) * 2002-09-13 2004-03-18 Tohru Araki Medicament for treatment of nocturia
DE60319252T2 (de) * 2002-09-21 2009-03-05 Zhang, Shuyi Formulierung von acetaminophen und tramadol mit verzögerter freisetzung
CN1791399A (zh) * 2003-03-21 2006-06-21 戴诺根医药品公司 用α2δ亚基钙通道调节剂和平滑肌调节剂一起治疗下泌尿道病症的方法
US20040186180A1 (en) * 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen
US8029822B2 (en) 2003-05-22 2011-10-04 Osmotica Kereskedelmi és Seolgáltató KFT Rupturing controlled release device having a preformed passageway
US20040248979A1 (en) * 2003-06-03 2004-12-09 Dynogen Pharmaceuticals, Inc. Method of treating lower urinary tract disorders
DE10356112A1 (de) 2003-11-27 2005-06-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Zusammensetzung aus einem Beta-3-Adrenozeptor-Agonisten und einem in den Prostglandinstoffwechsel eingreifendem Wirkstoff
EP1627876A1 (en) * 2004-08-20 2006-02-22 Ferring B.V. Heterocyclic condensed compounds useful as antidiuretic agents
JP2008511611A (ja) * 2004-08-30 2008-04-17 ルナメツド・インコーポレーテツド 治療用４−フェニル酪酸制御放出製剤
EP1879578A4 (en) * 2005-03-21 2009-05-13 Dov Pharmaceutical Inc METHODS AND COMPOSITIONS FOR THE TREATMENT OF URINARY INCONTINENCE
US20080300262A1 (en) * 2005-04-08 2008-12-04 Snutch Terrance P Combination Therapy for Relief of Pain
DE202006020331U1 (de) * 2005-07-20 2008-09-18 Panacea Biotec Ltd. Neue, pharmazeutische modifizierte Freisetzungs-Dosisform Cyclooxygenase-Enzym-Inhibitor
US20080166407A1 (en) 2005-07-29 2008-07-10 Shalaby Shalaby W Solid oral formulations for combination therapy
US20080085314A1 (en) * 2005-07-29 2008-04-10 Shalaby Shalaby W Solid oral formulations for combination therapy
WO2007072503A2 (en) * 2005-12-21 2007-06-28 Panacea Biotec Ltd. Combinations for managing inflammation and associated disorders
US20070237816A1 (en) * 2006-04-06 2007-10-11 David Finkelstein Acetaminophen formulation for joint pain relief
EP2068837A2 (en) 2006-07-28 2009-06-17 Dr. Reddy's Laboratories Ltd. Granular pharmaceutical compositions
US20080057122A1 (en) * 2006-08-31 2008-03-06 Aaipharma Inc. Acetaminophen pharmaceutical compositions
CA2696063C (en) * 2007-08-15 2014-05-06 Mcneil-Ppc, Inc. Immediate release and sustained release ibuprofen dosing form
GB201003731D0 (en) * 2010-03-05 2010-04-21 Univ Strathclyde Immediate/delayed drug delivery
JP2018016869A (ja) * 2016-07-29 2018-02-01 日立化成株式会社 アルミニウム系多孔質体及びその製造方法

Similar Documents

Publication Publication Date Title
JP2015503583A5 (cg-RX-API-DMAC7.html)
JP2009525343A5 (cg-RX-API-DMAC7.html)
JP2015506359A5 (cg-RX-API-DMAC7.html)
RU2014131238A (ru) Состав с отсроченным высвобождением для уменьшения частоты мочеиспускания и способ его применения
JP2015510928A5 (cg-RX-API-DMAC7.html)
PH12015502134A1 (en) Mosapride sustained-release preparation for providing pharmacological and clinical effects with once-a-day administration
JP2013517304A5 (cg-RX-API-DMAC7.html)
HRP20240564T1 (hr) Novi farmaceutski sastav
JP2015038135A5 (cg-RX-API-DMAC7.html)
JP2009541443A5 (cg-RX-API-DMAC7.html)
RU2017137643A (ru) Составы l-орнитин фенилацетата
HRP20171743T1 (hr) Sastavi i postupci za savladavanje otpornosti na tramadol
JP2012505884A5 (cg-RX-API-DMAC7.html)
RU2014142025A (ru) Препарат длительного высвобождения для снижения частоты мочеиспускания и способ его применения
JP2013209384A5 (cg-RX-API-DMAC7.html)
HRP20240045T1 (hr) Tablete s trenutnim oslobađanjem koje sadrže lijek i postupci za proizvodnju tableta
HRP20161340T1 (hr) Formulacije darunavira
AR052225A1 (es) Formulaciones de tabletas de liberacion modificada par inhibidores de la bomba de protones
US9668993B2 (en) Non-steroidal anti-inflammatory drug dosing regimen
JP2012082195A5 (cg-RX-API-DMAC7.html)
JP2015522659A5 (cg-RX-API-DMAC7.html)
JP2015522658A5 (cg-RX-API-DMAC7.html)
JP2012505830A5 (cg-RX-API-DMAC7.html)
JP2007509965A5 (cg-RX-API-DMAC7.html)
TWI629059B (zh) Antipyretic and analgesic composition